Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Am Acad Dermatol. 2010 Mar 23;64(1):84–90. doi: 10.1016/j.jaad.2010.01.041

CIGARETTE SMOKING AND MALIGNANT MELANOMA: A CASE-CONTROL STUDY

Maria C Kessides a, Lee Wheless b, Judith Hoffman-Bolton c,d, Sandra Clipp c,d, Rhoda M Alani a, Anthony J Alberg b,c
PMCID: PMC2924442  NIHMSID: NIHMS191073  PMID: 20334951

Abstract

Background

Several previous studies have reported inverse associations between cigarette smoking and melanoma. Often these studies have not adjusted for ultraviolet (UV) exposure history, skin type, or number of blistering sunburns, which could confound the observed associations between cigarette smoking and melanoma.

Objective

To assess whether this reported inverse association persists after adjusting for UV exposure, skin type, and number of blistering sunburns.

Methods

We conducted a population-based case-control study (82 melanoma cases, 164 controls). Two controls were matched to each case by age, sex, race, and skin type. Conditional logistic regression models were fit to assess the association between cigarette smoking history and melanoma, with additional adjustments for UV exposure and sunburns.

Results

Compared to never smokers, both former (OR 0.43, 95% CI 0.18–1.04) and current (OR 0.65, 95% CI 0.19–2.24) smoking were inversely associated with melanoma, but the associations were not statistically significant.

Limitations

The number of cutaneous nevi was not assessed in this study. Additionally, the relatively small number of cases limits the statistical precision of the observed associations.

Conclusions

After matching for age, sex, race, and skin type, and further adjusting for UV exposure and number of sunburns, cigarette smoking was not statistically significantly associated with melanoma risk, but the results were consistent with previous observations of an inverse association.

INTRODUCTION

Cigarette smoking is causally associated with cancers of the lung, bladder, pancreas kidney, oral cavity, esophagus, larynx and uterine cervix.1 Studies of cigarette smoking in relation to the risk of cutaneous malignant melanoma (CMM) have been reported, but the evidence to date has not been clear-cut. Surprisingly, the results have often suggested the possibility that smoking may be inversely associated with melanoma risk (Table 1).212 These previous findings raise the question as to whether these observed inverse associations are real or, rather, due to methodologic weaknesses of the studies.

Table 1.

Summary of studies that reported on the association between cigarette smoking and melanoma

Author (Year) Location Number melanoma cases Number of controls/subjects OR or RR1 (95% CI) Adjustments
Cohort Studies
Veierod (1997) Norway (registry-based) 108 50,757 total cohort (Norwegian National Health Screening) Former: 0.9 (0.5–1.4)
Curr <10/d: 0.6 (0.4–1.1)
Curr >10/d: 0.7(0.4–1.4)
Age, sex, county of residence
Freedman (2003) USA 140 68,588 total cohort Radiologic Technologists Study Former: 0.9 (0.7–1.3)
Current: 0.8 (0.5–1.1)
Age, sex, skin color, hair color, history of NMSC, residential history, sunlight exposure (proxy), alcohol, education
Odenbro (2007) Sweden 1639 339,802 total cohort of male construction workers Former: 0.8 (0.7–0.9)
Current: 0.6 (0.5–0.7)
Age, birth cohort, BMI, UV exposure(based on job task)
Case-Control Studies
Williams (1977) USA Not stated 7,518 controls with other cancers Males: 1.1, 0.4, 0.52
Females:1.1, 0.4, 0.92
Age, race, education, income, geographic location
Paffenbarger (1978) USA (Harvard alumni) 45 deaths 180 controls Ever: 1.4 (p= 0.4)
>10 per day: 0.8 (p= 0.7)
Age
Green (1986) Australia (Queensland) 183 236 controls matched by age, sex residence Low: 0.7 (0.2–2.1)
Med: 0.8 (0.3–2.4)
High: 1.3 (0.3–5.0)
Age, sex, residence location; skin type, lifetime sun exposure
Osterlind (1988) Denmark 474 (registry) 926 controls(population-based) Former:1.0 (0.7–1.3)
Current: 0.8 (0.6–1.1)
Uncertain
Siemiatycki (1995) Canada (Montreal) 103 (all men) 533 controls(population-based) Ever: 0.5 (0.3–0.9) Age, race, socioeconomic status, selected dietary factors
Westerdahl (1996) Sweden 327 (registry) 519 controls matched by sex, age, residence(population-based) Former: 1.0 (0.3–3.5)
Current: 0.7 (0.5–1.1)
Age, sex, residence location, hair color, nevi, sunburn history
De Hertog (2001) Netherlands 125 396 controls(hospital-based) Smokers: 0.8 (0.5–1.2) Age, sex, cumulative sun exposure
Shors (2001) USA (Washington) 386 (registry) 727 controls(population-based) Former: 0.8 (0.6–1.1)
Current: 0.6 (0.4–0.8)
Age, sex
1

Compared to referent category of never smokers = 1.0.

2

Odds ratios for three categories of increasing levels of cigarette use.

Before a definitive conclusion can be reached, inconsistencies in the evidence concerning the association between cigarette smoking and CMM need to be resolved. For instance, most of these previous studies have reported only weak inverse associations, raising the possibility that the observed inverse association may actually be indirect and due to potential confounding factors such as ultraviolet (UV) exposure history, number of blistering sunburns, or skin type,1012 which are well-established risk factors for melanoma. Even in previous studies that have attempted to control for UV exposure and skin type, the potential for residual confounding is a lingering issue because the measurement of UV exposure and skin type have not always been optimal. For example, when UV exposure has been accounted for at all, it has often been measured by proxy information such as job task classification2 or area of residence.3,12 Only one of the previous studies accounted for history of blistering sunburns (Table 1). However, in the five studies that did adjust for sun exposure and/or skin type24,7,10, all showed at least some evidence of an inverse association. We therefore designed the present case-control study to attempt to more completely account for potential confounding by skin type, sun exposure, and sunburn history.

MATERIALS AND METHODS

Study Design

This matched case-control study was designed within a larger parent study, the “Give Us a Clue to Cancer and Heart Disease” (CLUE II) cohort that is approved by the Institutional Review Board at the Johns Hopkins Bloomberg School of Public Health. The CLUE II cohort is a community-based prospective study that enrolled 32,898 volunteers in Washington County, Maryland from May 1st, 1989 to November 30th, 1989. At baseline, the demographic information collected from questionnaires included history of cigarette smoking, height, weight, and years of school completed.

Subsequent questionnaires have been sent to cohort members, with the 2007 questionnaire relevant to the present investigation because of its skin cancer focus. The 2007 survey was mailed to cohort members who had responded to at least one of the four previous follow-up surveys (n = 14,779), and who were at least 13 years of age at study baseline. This survey collected an updated medical history, with a focus on history of skin cancer, skin type, UV exposure history, sun protection habits, and smoking history. Because the data on the history of UV exposure, sunburns, and skin type were so critical to this investigation, the cases and controls for the present study were limited to those who completed the 2007 survey (n =8,186).

Pathologically confirmed incident cases of cutaneous melanoma, ICD 9 code 172 or ICD 10 codes D03 or C43, were ascertained via the Comstock Center Cancer Registry. Eligible cases were those who responded to the 2007 survey and had complete data on age, sex, race, and skin type. Cases were excluded if they had a prior history of any cancer except non-melanoma skin cancer. Based on these criteria, a total of 82 confirmed cases of malignant melanoma were identified and included in the present study. Cases were comprised of both melanoma in situ and invasive melanomas, and were diagnosed between 1990 and 2007.

As with the cases, controls were drawn from those who responded to the 2007 survey and who resided in or near Washington County, Maryland. From this pool of potential controls, those with a confirmed or self-reported history of any cancer, including nonmelanoma skin cancer, were excluded. Potential controls with missing information on age, sex, race, or skin type were also excluded. For each case, two controls, one younger and one older, were matched on sex, race, skin type, and age (± 5 years). All cases and controls were Caucasian.

Skin type was determined from the following responses to the question “If you spent an hour in the mid-day sun for the first time without sunscreen, which of these reactions best describes what would happen to your skin?”: blistering sunburn (skin type I), sunburn without blisters (skin type II), mild sunburn that becomes a tan (skin type III), tan or darken with no sunburn (skin type IV), or no change in skin color (skin types V/VI).

The primary independent variable was smoking history measured at baseline in 1989. Participants were classified as never, former, or current smokers. Those with a positive history of smoking were further classified according to the number of cigarettes (<20 or 20+) smoked per day.

Additional variables used in the analysis were the lifetime number of blistering sunburns, and the frequency and duration of sun exposure and sun protection behaviors. A series of questions from the 2007 survey asked the number of hours spent in the midday (10am–4pm) sun in the summer on both weekdays and weekends for different decades of the respondent’s lifetime (i.e. teens, twenties, thirties, and the past decade). Sun exposure was classified as low (0–1 hour per day), medium (2–3 hours per day), and high (4–6 hours per day). Regular use of sunscreen and sun protective clothing was defined by “often” or “always” engaging in that form of sun protection. Non-regular use of sunscreen and sun protective clothing was defined as “never,” “rarely,” or “sometimes” engaging in that form of sun protection.

Statistical analysis

The chi-square test was used to estimate p-values for case-control comparisons for gender, age, education, skin type, smoking status, UV exposure and number of blistering sunburns. To account for the matched design, conditional logistic regression was used to estimate odds ratios and 95% confidence limits for the association between cigarette smoking status in 1989 and melanoma. We performed ancillary analyses that accounted for the change in smoking status that could have occurred between 1989 and 2007. A two-sided p-value of 0.05 or less was considered to be statistically significant. All data analyses were performed using SAS 9.1 (SAS Institute, Cary, NC).

RESULTS

Cases and controls were matched exactly by gender and skin type, and had similar age distributions (Table 2). No significant case-control differences were observed for UV exposure history (p=0.56 for weekend exposure; p=0.92 for weekday exposure) or sunscreen use (p=0.13). Cases were significantly more likely than controls (p < 0.01) to report five or more blistering sunburns, but not 1–4 blistering sunburns (p=0.67).

Table 2.

Demographic characteristics, sun exposure history and skin cancer prevention behaviors among melanoma cases and matched controls*

Factor CASES (n=82) % CONTROLS (n=164) % P value
Gender 1.00
 Male 51.2 51,2
 Female 48.8 48.8
Age(years) 0.99
 40–49 8.3 7.7
 50–59 16.7 17.3
 60–69 25.0 25.0
 70–84 42.9 43.5
 85+ 7.1 6.6
Education 0.59
 Less than high school 13.1 16.1
 High school 39.3 42.9
 More than high school 47.6 41.1
Skin reaction to sunlight 1.00
 Blistering burn 13.4 13.4
 Burn without blisters 42.7 42.7
 Burn that tans 35.4 35.4
 Tan without burn 8.5 8.5
Midday sun exposure: weekend 0.63
 Low 52.8 47.4
 Medium 31.9 32.5
 High 15.3 20.1
Midday sun exposure: weekday 0.69
 Low 55.6 59.1
 Medium 33.3 27.9
 High 11.1 13.0
Lifetime blistering sunburns <0.01
 0 23.5 32.7
1–4 44.4 52.7
 5+ 32.1 14.6
Sunscreen Use
 Regular 26.8 23.2 0.53
 Non-regular 73.2 76.8
Sun-protective clothing use 0.11
 Regular 35.4 25.6
 Non-regular 64.6 74.4
*

Percentages calculated out of total cases and controls for whom there was sufficient information on UV exposure history and sun protective behaviors

Taken at midpoint of when the 2007 survey was in the field (09/01/2007)

Based on n=72 cases and n=154 controls Midday sun exposure during last decade

Cigarette smoking was inversely associated with melanoma risk, but none of these associations was statistically significant. In the analyses adjusted for the matching factors of age, race, sex, and skin type, compared to never smokers, there was a nonsignificant decrease in odds of melanoma among former smokers (OR 0.73, 95% CI 0.38–1.42), and among current smokers (OR 0.81, 95% CI 0.28–2.36) (Table 3). With further adjustments for UV exposure, sunburn history, sun-protective clothing and sunscreen use, compared to never smoking, the fully adjusted odds ratios were 0.43 for former smoking (95% CI 0.18–1.04), and 0.65 for current smoking (95% CI 0.19–2.24). In the adjusted models, compared to those with no previous blistering sunburns, history of 1–4 blistering sunburns was not significantly associated with melanoma risk (OR 1.98, 95% CI 0.69–5.69), but five or more blistering sunburns was significantly associated with increased melanoma risk (OR 5.42, 95% CI 1.66–17.64). The associations between regular sunscreen use, regular sun-protective clothing use, and lifetime sun exposures and melanoma were not statistically significant (p > 0.05 for each).

Table 3.

Odds ratios (and 95% confidence intervals) for the association between cigarette smoking and melanoma.

Smoking status Cases (n = 82) Controls (n=164) Odds Ratio (95% CI) Odds Ratio (95% CI)
% %
Never 59.2 55.8 1.00 (referent) 1.00 (referent)
Former 27.2 33.5 0.73 (0.38–1.42) 0.43 (0.18–1.04)
Current 13.6 10.7 0.81 (0.28–2.36) 0.65 (0.19–2.24)

Adjusted for matching factors of age, race, sex, and skin type

Adjusted for matching factors plus history of sunburns, sun-protective clothing use, sunscreen use, and sun exposure history

In analyses that accounted for the possible changes in smoking status that could occur between 1989 and 2007, compared to never smokers the odds ratio among current smokers in 1989 who had quit smoking by 2007 was 1.14 (95% CI 0.21–6.34) and in persistent smokers was 0.36 (95% CI 0.05–2.37).

DISCUSSION

By carefully matching on age, sex, race, and skin type, and by further adjusting for sun exposure history and history of blistering sunburns in the data analyses, our goal was to overcome limitations from previously published research on the association between cigarette smoking and melanoma. Using this design, we observed that the associations between cigarette smoking and melanoma persisted in the inverse direction, but were not statistically significant. In our study, the point estimates of the fully adjusted estimates of the odds ratio were consistently in the direction of decreased risk, 0.65 (95% CI 0.19–2.24) for current smoking and 0.43 (95% CI 0.18–1.04) for former smoking. Interestingly, the associations in the fully adjusted model were further from the null than the minimally adjusted analyses; that is, more complete control for potential confounding factors actually strengthened the inverse association rather than diminished it. The fact that the inverse association between cigarette smoking and malignant melanoma persisted after carefully controlling for skin type, UV exposure history and number of blistering sunburns suggests that previous observations of an inverse association may have not been due to confounding by these important melanoma risk factors. In fact, this raises the possibility that even more careful and complete control for potential confounding variables could potentially have resulted in stronger and statistically significant associations.

Some previous studies have observed an inverse association between cigarette smoking and melanoma.29 Often, the results of the individual studies were not statistically significant.37,9 Nonetheless, the primary drawback of these collective studies is the sub-optimal control for variables that would affect melanoma outcome, specifically UV exposure history, skin type, and history of blistering sunburns. For example, in the lone cohort study to report a statistically significant inverse association between cigarette smoking and melanoma, skin type was not controlled for and job task classification was used as a proxy measure for UV exposure.2

The matching on skin type and adjustment for UV exposure history and history of blistering sunburns in the present study provided inferential advantages lacking in previous studies. Further, our measurement of UV exposure history that included multiple decades of life is a more direct measure of sun exposure history than proxy measurements such as geographic region or county of residence.6,12 We adjusted for history of blistering sunburns, sunscreen and sun-protective clothing use, and lifetime sun exposures. Having five or more blistering sunburns was significantly associated with melanoma in our adjusted models. The association between the 1–4 blistering sunburn category and melanoma was in the direction of increased risk but was not statistically significant. Regular use of sun-protective clothing or sunscreen, and chronic sun exposure were not significantly associated with melanoma risk in these models, either. Despite the careful control for potential confounding in the present study, we acknowledge several limitations. Foremost among these is the relatively small number of melanoma cases. Even though we attempted to compensate for this by selecting two matched controls per case, the size of the study limited the degree of statistical precision, as evidenced by the relatively wide confidence intervals around the odds ratios. Another limitation in the design of our study was the fact that the melanoma cases may have had a personal history of nonmelanoma skin cancer, whereas a history of nonmelanoma skin cancer was an exclusion criteria for the control group. A history of nonmelanoma skin cancer is an established risk factor for melanoma13, and to the extent the association between NMSC and melanoma is independent of solar UV exposure, this may have introduced a bias. This would be of even more concern if cigarette smoking was associated with nonmelanoma skin cancer, but the evidence to date does not support a consistent association14. Furthermore, we do not have knowledge of full body skin examinations or adherence to health maintenance examinations among the study participants. This, along with absence of information on nevi, introduces the possibility that there may have been some cohort members with melanoma that was not yet clinically diagnosed when this study was carried out. This would introduce potential biases, but we expect the number of such cases to be small and therefore not a major concern. We also did not measure the number or classification of cutaneous nevi. The presence of atypical or dysplastic nevi is associated with substantially increased melanoma risk, with more nevi conferring a greater risk.1522 Moreover, even an increased number of banal-appearing nevi confers a two- to four-fold elevated risk for melanoma.21 Thus, future studies that incorporate a larger number of subjects and control for the number of total body nevi will help to better elucidate the relationship between cigarette smoking and melanoma.

CONCLUSION

After carefully controlling for age, sex, race, skin type, UV exposure history, and history of blistering sunburns, we observed that, compared to never smokers, former smokers had a roughly 60% decreased risk of melanoma and current smokers had a 35% decreased risk. Even though the findings were not statistically significant, that we observed evidence of an inverse association between cigarette smoking and the development of malignant melanoma even after carefully controlling for skin type, UV exposure history and number of blistering sunburns suggests that previous reports of a potential inverse association may not have been due to confounding by these important melanoma risk factors. The possibility that cigarette smoking is inversely associated with melanoma therefore cannot be ruled out.

Acknowledgments

This research was supported by RO1 CA105069 from the National Cancer Institute, as well as a grant from the Doris Duke Charitable Foundation to Johns Hopkins University School of Medicine (Clinical Research Fellow Maria Kessides), and T32RR023258 from the National Center for Research Resources (Lee Wheless).

Abbreviations

UV

Ultraviolet

CMM

Cutaneous malignant melanoma

NMSC

Nonmelanoma skin cancer

Footnotes

Disclosure: The authors have no conflict of interest to declare

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Department of Health and Human Services, Centers for Disease Control and Prevention. The health consequences of smoking: A report of the surgeon general. Atlanta, GA: Department of Health and Human Services; 2004. [Google Scholar]
  • 2.Odenbro A, Gillgren P, Bellocco R, Boffetta P, Hakansson N, Adami J. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol. 2007 Jan;156(1):99–105. doi: 10.1111/j.1365-2133.2006.07537.x. [DOI] [PubMed] [Google Scholar]
  • 3.Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control. 2003 Nov;14(9):847–57. doi: 10.1023/b:caco.0000003839.56954.73. [DOI] [PubMed] [Google Scholar]
  • 4.De Hertog SA, Wensveen CA, Bastiaens MT, Kielich CJ, Berkhout MJ, Westendorp RG, et al. Relation between smoking and skin cancer. J Clin Oncol. 2001 Jan 1;19(1):231–8. doi: 10.1200/JCO.2001.19.1.231. [DOI] [PubMed] [Google Scholar]
  • 5.Shors AR, Solomon C, McTiernan A, White E. Melanoma risk in relation to height, weight, and exercise (United States) Cancer Causes Control. 2001 Sep;12(7):599–606. doi: 10.1023/a:1011211615524. [DOI] [PubMed] [Google Scholar]
  • 6.Veierod MB, Thelle DS, Laake P. Diet and risk of cutaneous malignant melanoma: A prospective study of 50,757 norwegian men and women. Int J Cancer. 1997 May 16;71(4):600–4. doi: 10.1002/(sici)1097-0215(19970516)71:4<600::aid-ijc15>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  • 7.Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N. Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer. 1996 May;73(9):1126–31. doi: 10.1038/bjc.1996.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Siemiatycki J, Krewski D, Franco E, Kaiserman M. Associations between cigarette smoking and each of 21 types of cancer: A multi-site case-control study. Int J Epidemiol. 1995 Jun;24(3):504–14. doi: 10.1093/ije/24.3.504. [DOI] [PubMed] [Google Scholar]
  • 9.Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish Case-Control Study of cutaneous malignant melanoma. IV. no association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer. 1988 Dec 15;42(6):825–8. doi: 10.1002/ijc.2910420604. [DOI] [PubMed] [Google Scholar]
  • 10.Green A, Bain C, McLennan R, Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res. 1986;102:76–97. doi: 10.1007/978-3-642-82641-2_6. [DOI] [PubMed] [Google Scholar]
  • 11.Paffenbarger RS, Jr, Wing AL, Hyde RT. Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: Brief communication. J Natl Cancer Inst. 1978 Jan;60(1):89–92. doi: 10.1093/jnci/60.1.89. [DOI] [PubMed] [Google Scholar]
  • 12.Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the third national cancer survey. J Natl Cancer Inst. 1977 Mar;58(3):525–47. doi: 10.1093/jnci/58.3.525. [DOI] [PubMed] [Google Scholar]
  • 13.Gruber SB, Armstrong BK. Cutaneous and ocular melanoma. In: Schottenfeld D, Fraumeni JF Jr , editors. Cancer epidemiology and prevention. 3. Chapter 63. Oxford University Press; New York: 2006. pp. 1196–1229. [Google Scholar]
  • 14.Karagas MR, Weinstock MA, Nelson HH. Keratinocyte carcinomas (basal and squamous cell carcinomas of the skin) In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3. Chapter 64. Oxford University Press; New York: 2006. pp. 1230–1250. [Google Scholar]
  • 15.Nordlund JJ, Kirkwood J, Forget BM, Scheibner A, Albert DM, Lerner E, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985 Apr;45(4):1855–61. [PubMed] [Google Scholar]
  • 16.Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987 Sep;17(3):459–68. doi: 10.1016/s0190-9622(87)70230-8. [DOI] [PubMed] [Google Scholar]
  • 17.MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989 Aug 26;2(8661):487–90. doi: 10.1016/s0140-6736(89)92097-7. [DOI] [PubMed] [Google Scholar]
  • 18.Halpern AC, Guerry D, 4th, Elder DE, Clark WH, Jr, Synnestvedt M, Norman S, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol. 1991 Jul;127(7):995–9. [PubMed] [Google Scholar]
  • 19.Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: Multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol. 1994 May;102(5):695–9. doi: 10.1111/1523-1747.ep12374280. [DOI] [PubMed] [Google Scholar]
  • 20.Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton Bishop J, McCarthy W, et al. The association between naevi and melanoma in populations with different levels of sun exposure: A joint case-control study of melanoma in the UK and australia. Br J Cancer. 1998;77(3):505–10. doi: 10.1038/bjc.1998.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA. 1997 May 14;277(18):1439–44. [PubMed] [Google Scholar]
  • 22.Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA, et al. Combined risk factors for melanoma in a mediterranean population. Br J Cancer. 2001 Nov 2;85(9):1304–10. doi: 10.1054/bjoc.2001.2029. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES